Literature DB >> 28476734

The Call of "The Wild"-Type GIST: It's Time for Domestication.

Maha Alkhuziem, Adam M Burgoyne, Paul T Fanta, Chih-Min Tang, Jason K Sicklick.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28476734      PMCID： PMC5549855          DOI： 10.6004/jnccn.2017.0057

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  10 in total

1.  Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST.

Authors:  Monica Brenca; Sabrina Rossi; Maurizio Polano; Daniela Gasparotto; Lucia Zanatta; Dominga Racanelli; Laura Valori; Stefano Lamon; Angelo Paolo Dei Tos; Roberta Maestro
Journal:  J Pathol       Date:  2016-01-25       Impact factor: 7.996

2.  Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.

Authors:  Daniela Gasparotto; Sabrina Rossi; Maurizio Polano; Elena Tamborini; Erica Lorenzetto; Marta Sbaraglia; Alessia Mondello; Marco Massani; Stefano Lamon; Raffaella Bracci; Alessandra Mandolesi; Elisabetta Frate; Franco Stanzial; Jerin Agaj; Guido Mazzoleni; Silvana Pilotti; Alessandro Gronchi; Angelo Paolo Dei Tos; Roberta Maestro
Journal:  Clin Cancer Res       Date:  2016-07-07       Impact factor: 12.531

3.  Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.

Authors:  Sosipatros A Boikos; Alberto S Pappo; J Keith Killian; Michael P LaQuaglia; Chris B Weldon; Suzanne George; Jonathan C Trent; Margaret von Mehren; Jennifer A Wright; Josh D Schiffman; Margarita Raygada; Karel Pacak; Paul S Meltzer; Markku M Miettinen; Constantine Stratakis; Katherine A Janeway; Lee J Helman
Journal:  JAMA Oncol       Date:  2016-07-01       Impact factor: 31.777

4.  STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications.

Authors:  D A Tuveson; N A Willis; T Jacks; J D Griffin; S Singer; C D Fletcher; J A Fletcher; G D Demetri
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

5.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

6.  Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic.

Authors:  Christopher B Weldon; Arin L Madenci; Sosipatros A Boikos; Katherine A Janeway; Suzanne George; Margaret von Mehren; Alberto S Pappo; Joshua D Schiffman; Jennifer Wright; Jonathan C Trent; Karel Pacak; Constantine A Stratakis; Lee J Helman; Michael P La Quaglia
Journal:  J Clin Oncol       Date:  2016-12-28       Impact factor: 44.544

7.  PDGFRA activating mutations in gastrointestinal stromal tumors.

Authors:  Michael C Heinrich; Christopher L Corless; Anette Duensing; Laura McGreevey; Chang-Jie Chen; Nora Joseph; Samuel Singer; Diana J Griffith; Andrea Haley; Ajia Town; George D Demetri; Christopher D M Fletcher; Jonathan A Fletcher
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

8.  Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST).

Authors:  Margherita Nannini; Annalisa Astolfi; Milena Urbini; Valentina Indio; Donatella Santini; Michael C Heinrich; Christopher L Corless; Claudio Ceccarelli; Maristella Saponara; Anna Mandrioli; Cristian Lolli; Giorgio Ercolani; Giovanni Brandi; Guido Biasco; Maria A Pantaleo
Journal:  BMC Cancer       Date:  2014-09-20       Impact factor: 4.430

9.  FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

Authors:  Eileen Shi; Juliann Chmielecki; Chih-Min Tang; Kai Wang; Michael C Heinrich; Guhyun Kang; Christopher L Corless; David Hong; Katherine E Fero; James D Murphy; Paul T Fanta; Siraj M Ali; Martina De Siena; Adam M Burgoyne; Sujana Movva; Lisa Madlensky; Gregory M Heestand; Jonathan C Trent; Razelle Kurzrock; Deborah Morosini; Jeffrey S Ross; Olivier Harismendy; Jason K Sicklick
Journal:  J Transl Med       Date:  2016-12-14       Impact factor: 5.531

10.  Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.

Authors:  Chih-Min Tang; Tracy E Lee; Sabriya A Syed; Adam M Burgoyne; Stephanie Y Leonard; Fei Gao; Jonathan C Chan; Eileen Shi; Juliann Chmielecki; Deborah Morosini; Kai Wang; Jeffrey S Ross; Michael L Kendrick; Michael R Bardsley; Martina De Siena; Junhao Mao; Olivier Harismendy; Tamas Ordog; Jason K Sicklick
Journal:  Oncotarget       Date:  2016-11-29
  10 in total
  6 in total

Review 1.  Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors.

Authors:  Pushpa Neppala; Sudeep Banerjee; Paul T Fanta; Mayra Yerba; Kevin A Porras; Adam M Burgoyne; Jason K Sicklick
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

2.  Anti-KIT DNA Aptamer for Targeted Labeling of Gastrointestinal Stromal Tumor.

Authors:  Jason K Sicklick; Partha Ray; Sudeep Banerjee; Hyunho Yoon; Mayra Yebra; Chih-Min Tang; Mara Gilardi; Jayanth S Shankara Narayanan; Rebekah R White
Journal:  Mol Cancer Ther       Date:  2020-03-03       Impact factor: 6.261

3.  KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor.

Authors:  Sudeep Banerjee; Hyunho Yoon; Stephanie Ting; Chih-Min Tang; Mayra Yebra; Alexander T Wenzel; Huwate Yeerna; Jill P Mesirov; Robert J Wechsler-Reya; Pablo Tamayo; Jason K Sicklick
Journal:  Mol Cancer Ther       Date:  2021-08-10       Impact factor: 6.261

4.  Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras.

Authors:  Michael J Cavnar; Kenneth Seier; Christina Curtin; Vinod P Balachandran; Daniel G Coit; Sam S Yoon; Aimee M Crago; Vivian E Strong; William D Tap; Mithat Gönen; Cristina R Antonescu; Murray F Brennan; Sam Singer; Ronald P DeMatteo
Journal:  Ann Surg       Date:  2021-01-01       Impact factor: 13.787

Review 5.  Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor.

Authors:  Jiehan Li; Shuning Guo; Zhenqiang Sun; Yang Fu
Journal:  Front Cell Dev Biol       Date:  2022-01-31

6.  Location of Gastrointestinal Stromal Tumor (GIST) in the Stomach Predicts Tumor Mutation Profile and Drug Sensitivity.

Authors:  Ashwyn K Sharma; Jorge de la Torre; Nikki S IJzerman; Thomas L Sutton; Beiqun Zhao; Tahsin M Khan; Sudeep Banerjee; Christina Cui; Vi Nguyen; Maha Alkhuziem; Petur Snaebjornsson; Hester van Boven; Annemarie Bruining; Chih-Min Tang; Hyunho Yoon; Alexa De la Fuente; Shumei Kato; Hitendra Patel; Michael C Heinrich; Christopher L Corless; Santiago Horgan; Adam M Burgoyne; Paul Fanta; Jill P Mesirov; Andrew M Blakely; Jeremy L Davis; Skye C Mayo; Winan J van Houdt; Neeltje Steeghs; Jason K Sicklick
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.